.Psyence Biomedical is paying for $500,000 in allotments to obtain fellow psilocybin-based biotech C...
.Five months after accepting Power Therapeutics' Pivya as the first new therapy for uncomplicated ur...
.Eli Lilly has actually sprung in to an AI-enabled drug discovery bargain, partnering along with RNA...
.Lykos CEO and owner Amy Emerson is actually stepping down, with main working officer Michael Mullet...
.Novartis levels a new frontier in its collaboration with Voyager Rehabs, spending $15 thousand to o...
.On the heels of an FDA rejection for its own chief competing Novo Nordisk, Eli Lilly is pulling ahe...
.Merely a couple of months after dosing the very first individual in a stage 2 trial for newly diagn...
.Eli Lilly's hunt for weight problems targets has actually led it to the black genome. The Big Pharm...
.Toolbox Biosciences is going on up. The cell treatment firm has added on $325 million in ammo with ...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...